跳至主要内容
临床试验/NCT02191631
NCT02191631已完成不适用

Internet-delivered Cognitive Behavior Therapy for Adolescents With Obsessive-Compulsive Disorder: A Randomized Controlled Study

Karolinska Institutet2 个研究点 分布在 1 个国家目标入组 67 人开始时间: 2014年8月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
67
试验地点
2
主要终点
Children's Yale Brown Obsessive Compulsive Scale, CY-BOCS

研究概览

简要总结

The effect of Internet-delivered Cognitive Behavior Therapy (ICBT) on adolescents (12 to 17 years) with Obsessive-Compulsive Disorder is studied. Participants are randomized to either ICBT or a no-treatment condition. We expect ICBT to be superior over the no-treatment condition.

详细描述

The primary objective of this study is to test the efficacy of Internet-delivered cognitive behavior therapy (ICBT) for adolescents (12 - 17 years) with OCD. We aim to conduct a randomized controlled study with N = 66 participants. Participants will be randomly assigned to ICBT or a wait list condition, either lasting 12 weeks. The primary outcome measure is the Children's Yale-Brown Obsessive Compulsive Scale (CY-BOCS). Study participants will be followed up 3 and 12 months after treatment. ICBT is expected to yield significantly better symptom reduction than the wait list condition.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Outcomes Assessor)

入排标准

年龄范围
12 Years 至 17 Years(Child)
性别
All
接受健康志愿者

入选标准

  • a primary diagnosis of OCD as defined by DSM-5
  • a total score of ≥ 16 on the Children's Yale-Brown Obsessive-Compulsive Scale, CY-BOCS
  • age between 12 and 17 years
  • ability to read and write Swedish
  • daily access to the internet
  • a parent that is able to co-participate in the treatment
  • Participants on psychotropic medication must have been on a stable dose for the last 6 weeks prior to baseline assessment

排除标准

  • diagnosed autism spectrum disorder, psychosis or bipolar disorder, severe eating disorder
  • suicidal ideation
  • ongoing substance dependence
  • subject not able to read or understand the basics of the ICBT material
  • completed CBT for OCD within last 12 months (defined as at least 5 sessions of CBT including exposure and response prevention)
  • ongoing psychological treatment for OCD or another anxiety disorder

结局指标

主要结局

Children's Yale Brown Obsessive Compulsive Scale, CY-BOCS

时间窗: Baseline, 12 weeks after treatment starts, 3 and 12 months after treatment has ended

Change from Baseline of obsessions and compulsions after 12 weeks and at 3- and 12 months after treatment

次要结局

  • Clinical Global Impression - Improvement, CGI-I(Baseline, 12 weeks after treatment starts, 3 and 12 months after treatment has ended)
  • Family Accommodation Scale, Parent-Report (FAS-PR, Flessner et al., 2009)(Baseline, 12 weeks after treatment starts, 3 and 12 months after treatment has ended)
  • EQ-5D - quality of life(Baseline, 12 weeks after treatment starts, 3 and 12 months after treatment has ended)
  • Parent Adherence EX/RP Scale, PEAS(Baseline, 6 and 12 weeks after treatment starts)
  • Children's Obsessional Compulsive Inventory Revised, (CHOCI-R, Shafran et al., 2003)(Baseline, 12 weeks after treatment starts, 3 and 12 months after treatment has ended)
  • Education, Work and Social Adjustment Scale - child and parent version (EWSAS)(Baseline, 12 weeks after treatment starts, 3 and 12 months after treatment has ended)
  • Spence Child Anxiety Scale - Child and Parent version (SCAS-C/P, Spence, 1998(Baseline, 12 weeks after treatment starts, 3 and 12 months after treatment has ended)
  • Child Depression Inventory - Short version (CDI-S, Kovacs, 1985)(Baseline, 12 weeks after treatment starts, 3 and 12 months after treatment has ended)
  • Technology acceptance scale(Baseline, 6 and 12 weeks after treatment starts,)
  • Trimbos/iMTA questionnaire for Costs associated with Psychiatric Illness - Child version (TiC-P)(Baseline, 12 weeks after treatment starts, 3 and 12 months after treatment has ended)
  • Clinical Global Impression - Severity, CGI-S(Baseline, 12 weeks after treatment starts, 3 and 12 months after treatment has ended)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Eva Serlachius

MD, PhD

Karolinska Institutet

研究点 (2)

Loading locations...

相似试验